Talazoparib Beyond Brca: A Phase Ii Trial Of Talazoparib Monotherapy In Brca1 And Brca2 Wild-Type Patients With Advanced Her2-Negative Breast Cancer Or Other Solid Tumors With A Mutation In Homologous Recombination (Hr) Pathway Genes.

JOURNAL OF CLINICAL ONCOLOGY(2019)

引用 53|浏览24
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要